HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
W Douglas Cress Selected Research
W Douglas Cress Research Topics
Disease
20
Neoplasms (Cancer)
12/2023 - 05/2004
13
Lung Neoplasms (Lung Cancer)
01/2021 - 09/2004
5
Adenocarcinoma of Lung
12/2016 - 11/2012
4
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 12/2010
3
Melanoma (Melanoma, Malignant)
12/2023 - 01/2011
2
Breast Neoplasms (Breast Cancer)
11/2012 - 01/2011
2
Ovarian Neoplasms (Ovarian Cancer)
01/2011 - 11/2008
1
Neoplasm Metastasis (Metastasis)
01/2018
1
Inflammation (Inflammations)
01/2015
1
Retinoblastoma (Glioblastoma, Retinal)
01/2015
1
Adenocarcinoma
01/2014
1
Osteosarcoma (Osteogenic Sarcoma)
11/2010
1
Hypoxia (Hypoxemia)
07/2008
1
Infections
02/2004
1
Carcinoma (Carcinomatosis)
01/2003
Drug/Important Bio-Agent (IBA)
5
Proteins (Proteins, Gene)
FDA Link
01/2018 - 01/2003
4
Biomarkers (Surrogate Marker)
IBA
01/2018 - 01/2016
4
Phosphotransferases (Kinase)
IBA
01/2016 - 02/2004
4
Messenger RNA (mRNA)
IBA
01/2015 - 05/2004
2
Cytokines
IBA
11/2019 - 01/2011
2
Cadherins (E-Cadherin)
IBA
01/2018 - 01/2014
2
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
12/2017 - 01/2016
2
Cyclin-Dependent Kinases (cdk Proteins)
IBA
10/2017 - 10/2009
2
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
01/2016 - 01/2015
1
palbociclib
IBA
01/2021
1
abemaciclib
IBA
01/2021
1
p21-Activated Kinases
IBA
01/2021
1
Monomeric GTP-Binding Proteins
IBA
01/2021
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
11/2019
1
Type I Tumor Necrosis Factor Receptors
IBA
11/2019
1
MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)
IBA
11/2019
1
DNA (Deoxyribonucleic Acid)
IBA
12/2017
1
Platinum
IBA
01/2016
1
Platinum Compounds (Compounds, Platinum)
IBA
01/2016
1
Phenformin (Fenformin)
IBA
01/2016
1
adavosertib
IBA
01/2016
1
Estrogens (Estrogen)
FDA Link
10/2015
1
Estrogen Receptor alpha
IBA
10/2015
1
tyrosine receptor (receptor, tyrosine)
IBA
10/2015
1
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
IBA
01/2015
1
N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamide
IBA
01/2015
1
Tumor Suppressor Proteins (Proteins, Tumor Suppressor)
IBA
01/2015
1
Niflumic Acid
IBA
01/2015
1
Prostaglandins
IBA
01/2015
1
Perforin
IBA
03/2014
1
Taxoids (Taxanes)
IBA
01/2014
1
HLM006474
IBA
01/2014
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2014
1
Gefitinib (Iressa)
FDA Link
01/2014
1
Crizotinib
IBA
01/2014
1
Transcription Factors (Transcription Factor)
IBA
01/2014
1
Paclitaxel (Taxol)
FDA Link
Generic
01/2014
1
Tripartite Motif-Containing Protein 28
IBA
11/2012
1
Indicators and Reagents (Reagents)
IBA
12/2011
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
01/2011
1
necdin
IBA
01/2011
1
Valproic Acid (Depakote)
FDA Link
Generic
12/2010
1
Histone Deacetylase Inhibitors
IBA
12/2010
1
Panobinostat
IBA
12/2010
1
Checkpoint Kinase 1
IBA
12/2010
1
scriptaid
IBA
12/2010
1
entinostat (MS 275)
IBA
12/2010
1
apicidin
IBA
12/2010
1
Retinoblastoma Protein
IBA
11/2010
1
RNA (Ribonucleic Acid)
IBA
07/2008
1
STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)
IBA
07/2008
1
Cyclin-Dependent Kinase 2
IBA
02/2004
1
Cyclin A
IBA
02/2004
1
alvocidib (flavopiridol)
IBA
01/2003
Therapy/Procedure
10
Therapeutics
12/2023 - 05/2004
1
Adjuvant Chemotherapy
12/2016
1
Drug Therapy (Chemotherapy)
01/2016